Melnyk fires parting shot as Biovail and Valeant merge
This article was originally published in Scrip
Executive Summary
Eugene Melnyk, the founder of Biovail and persistent thorn in the side of the Canadian biotech has again voiced his concerns over the company's management as its merger with Valeant Pharmaceuticals closed.